Clinical trial Recruiting at 1 site Interventional Ages 20 to 80

Remimazolam and Sevoflurane: How they work together during anesthesia

Official title: Response Surface Model Between Remimazolam and Sevoflurane; Comparison of the Minto and the Greco Model

Run by Pusan National University Yangsan Hospital · NCT07620782 · Data updated 2026-11-12

This study tests how remimazolam and sevoflurane interact during general anesthesia in adults undergoing laparoscopic surgery to see if their combined effect is stronger, the same, or weaker than expected.

Quick facts

Study typeInterventional
Ages20 Years to 80 Years
SexAll
Enrollment80 (estimated)
SponsorPusan National University Yangsan Hospital
Academic / other
Locations1 site (Yangsan)
StatusRecruiting
StartedMay 15, 2026
Main results expectedApril 1, 2027
Study endsDecember 31, 2027
Registry record updatedJune 2, 2026
Trial IDNCT07620782 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 20–80 years scheduled for elective laparoscopic surgery under general anesthesia (ASA I–II) at Pusan National University Yangsan Hospital.

Probably not a fit

Patients whose anesthetic depth is not influenced by the combination or whose conditions prevent reliable modeling may not benefit from the study insights.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective randomized study examines the pharmacodynamic interaction between remimazolam and sevoflurane using response surface modeling. It analyzes BIS values and predicted effect-site concentrations with NONMEM to characterize whether the combination is synergistic, additive, or infra-additive. Two established interaction models, the Minto model and the Greco model, will be applied to data from adult patients undergoing elective laparoscopic surgery. The goal is to clarify how these agents influence anesthetic depth and to improve dosing strategies.

Why it matters

Potential benefit: If successful, the findings could improve dosing guidance for combined remimazolam and sevoflurane use, potentially enhancing anesthesia safety and stability.

How similar studies have gone: Previous work has explored interactions between anesthetic agents, with response surface modeling emerging as a method to understand combos; this study applies that approach to a newer benzodiazepine and volatile anesthetic pairing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 20 to 80 years
* Scheduled for elective surgery under general anesthesia at Pusan National University Yangsan Hospital
* American Society of Anesthesiologists (ASA) physical status I or II
* Able to provide written informed consent

Exclusion Criteria:

* Known allergy to remimazolam or sevoflurane
* Renal, hepatic, neuromuscular, or neurological disease
* Use of medications affecting the central nervous system
* Chronic psychoactive drug use
* Ischemic heart disease
* Pregnant women

Where it's running

  • Pusan National University Yangsan Hospital
    Yangsan, South Korea
    Recruiting

Study contacts

  • Principal investigator: Hee Young Kim, MD, PhD — Pusan National University Yangsan Hospital, Yangsan, South Korea
  • Study coordinator: Hee Young Kim, MD, PhD
  • Email: anekhy@gmail.com
  • Phone: 82-55-360-2129

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.